E Despierre

Summary

Affiliation: Katholieke Universiteit Leuven
Country: Belgium

Publications

  1. doi request reprint The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
    E Despierre
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium
    Gynecol Oncol 117:358-65. 2010
  2. doi request reprint Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy
    E Despierre
    Gynecologic Oncology and Leuven Cancer Institute, University Hospitals Leuven, Department of Oncology, KU Leuven, Belgium
    Gynecol Oncol 130:192-9. 2013
  3. ncbi request reprint Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
    E Despierre
    Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
    Int J Gynecol Cancer 16:273-7. 2006

Detail Information

Publications3

  1. doi request reprint The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
    E Despierre
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium
    Gynecol Oncol 117:358-65. 2010
    ..Recently, high-resolution genomic maps generated by genome-wide SNP analyses and novel sequencing technologies, have started to dissect the genetic basis of ovarian cancer...
  2. doi request reprint Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy
    E Despierre
    Gynecologic Oncology and Leuven Cancer Institute, University Hospitals Leuven, Department of Oncology, KU Leuven, Belgium
    Gynecol Oncol 130:192-9. 2013
    ..We evaluated whether chemotherapy modified FRA expression in non-mucinous epithelial ovarian (EOC) and endometrial carcinoma (EC)...
  3. ncbi request reprint Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
    E Despierre
    Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
    Int J Gynecol Cancer 16:273-7. 2006
    ..The documentation of chemosensitivity might enable the clinician to select a subpopulation of patients with widespread SEC that might benefit from interval debulking surgery...